Cendakimab Antibody
Cendakimab (RPC4046) is a humanized monoclonal antibody designed to selectively inhibit interleukin-13 (IL-13) by targeting its receptors, IL13R-α1 and IL13R-α2. It is utilized in preclinical research, including in vitro and in vivo studies, for investigating pathways in atopic dermatitis and related allergic diseases.
Product Specifications
Product Name Alternative
RPC4046, RPC 4046, ABT308, ABT-308, CC93538, CC 93538
Target
Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
7.9 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
146.44 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PC100558-01 100 mg
5- (tert-Butyl) 1-ethyl 2- (2-fluorophenyl) pentanedioate
Sign In for Pricing
View Details PC100558-02 250 mg
5- (tert-Butyl) 1-ethyl 2- (2-fluorophenyl) pentanedioate
Sign In for Pricing
View Details PC100558-03 1 g
5- (tert-Butyl) 1-ethyl 2- (2-fluorophenyl) pentanedioate
Sign In for Pricing
View Details PC100558-04 5 g
5- (tert-Butyl) 1-ethyl 2- (2-fluorophenyl) pentanedioate
Sign In for Pricing
View Details